methods for treating, reducing the incidence of, and / or preventing ischemic events

摘要

abstract methods of treating, reducing the incidence of, and / or preventing an ischemic event in a patient undergoing percutaneous coronary intervention (pci), comprising administering to the patient a pharmaceutical composition including cangrelor. the method may further compriseing an additional therapeutic agent to the patient, the additional therapeutic agent comprising a p2y12 inhibitor. pharmaceutical compositions useful for treating, reducing the incidence of, and / or preventing an ischemic event in a patient undergoing pci. the pharmaceutical compositions comprising cangrelor. methods of preparing a pharmaceutical composition for treating, reducing the incidence of, and / or preventing an ischemic event in a patient undergoing pci, comprising admixing cangrelor with one or more pharmaceutically acceptable excipients. An ischemic event may include stent thrombosis, myocardial infarction, ischemia-driven revascularization, and mortality. "Methods for treating, reducing the incidence of, and / or preventing ischemic events." These are methods for treating, reducing the incidence of, and / or preventing an ischemic event in a patient undergoing percutaneous coronary intervention (pci) comprising administering to the patient a pharmaceutical composition comprising cangrelor. The method may further comprise administering an additional therapeutic agent to the patient, the additional therapeutic agent comprising a p2y12 inhibitor. pharmaceutical compositions useful for treating, reducing the incidence of, and / or preventing an ischemic event in a patient undergoing pci. the pharmaceutical compositions comprise cangrelor. methods for preparing a pharmaceutical composition for treating, reducing the incidence of, and / or preventing an ischemic event in a patient undergoing pci, comprising admixing cangrelor with one or more pharmaceutically acceptable excipients. An ischemic event may include stent thrombosis, myocardial infarction, ischemia-led revascularization, and mortality. 1/1